Parker-Kerrigan et al. transfected 10 unique siRNAs into glioblastoma and bladder cancer cell lines, which led to the depletion of the FGFR3-TACC3 fusion protein, while wildtype FGFR3 was not affected [96]. This evidence concerns the gene TACC3 and urinary bladder cancer.